Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Wave’s Huntington Drugs Wipe Out As Trials Run Aground
WVE-120102 And WVE-120101 Fail To Show Benefit
30 Mar 2021
•
By
Alaric DeArment
The company now turns to its next-generation Huntington drug, WVE-003.
Wave is moving on to next-generation drug WVE-003 after its first-generation Huntington drugs failed. • Source: Shutterstock
More from R&D
More from Scrip